Acute Phase Response as a Biological Mechanism-of-Action of (Nano)particle-Induced Cardiovascular Disease

Small. 2020 May;16(21):e1907476. doi: 10.1002/smll.201907476. Epub 2020 Mar 29.

Abstract

Inhaled nanoparticles constitute a potential health hazard due to their size-dependent lung deposition and large surface to mass ratio. Exposure to high levels contributes to the risk of developing respiratory and cardiovascular diseases, as well as of lung cancer. Particle-induced acute phase response may be an important mechanism of action of particle-induced cardiovascular disease. Here, the authors review new important scientific evidence showing causal relationships between inhalation of particle and nanomaterials, induction of acute phase response, and risk of cardiovascular disease. Particle-induced acute phase response provides a means for risk assessment of particle-induced cardiovascular disease and underscores cardiovascular disease as an occupational disease.

Keywords: C-reactive protein; Serum Amyloid A; atherosclerosis; cardiovascular diseases; nanoparticles; occupational exposure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute-Phase Reaction* / chemically induced
  • Cardiovascular Diseases* / chemically induced
  • Humans
  • Inhalation Exposure* / adverse effects
  • Lung / drug effects
  • Nanoparticles* / toxicity
  • Occupational Diseases / chemically induced
  • Particle Size
  • Particulate Matter / toxicity

Substances

  • Particulate Matter